Savaria Co. (TSE:SIS – Get Free Report) has received a consensus recommendation of “Buy” from the six ratings firms that are presently covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a buy recommendation. The average 12-month price target among brokerages that have covered the stock in the last year is C$26.67.
SIS has been the subject of a number of recent analyst reports. TD Securities upped their target price on Savaria from C$24.00 to C$27.00 and gave the company a “buy” rating in a report on Thursday, November 6th. Scotiabank raised their target price on shares of Savaria from C$25.00 to C$26.00 in a research report on Monday, November 10th. National Bank Financial lifted their target price on shares of Savaria from C$26.00 to C$30.00 in a research note on Monday, December 22nd. Finally, Stifel Nicolaus boosted their price target on shares of Savaria from C$26.00 to C$28.00 and gave the company a “buy” rating in a research report on Wednesday, January 14th.
Read Our Latest Analysis on Savaria
Savaria Trading Up 0.5%
Savaria (TSE:SIS – Get Free Report) last released its quarterly earnings results on Wednesday, November 5th. The company reported C$0.32 EPS for the quarter. The business had revenue of C$224.77 million during the quarter. Savaria had a return on equity of 8.24% and a net margin of 5.34%. As a group, equities research analysts expect that Savaria will post 1.2048518 earnings per share for the current fiscal year.
Savaria Company Profile
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Further Reading
- Five stocks we like better than Savaria
- The AI Arms Race Has a New Contender: VWAV
- The DoD just got a new drone supplier
- Trump’s next major investment
- Is THIS the Next Big Money Rush?
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
